Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Influence of the Thickening of Bowman's Capsule on the Clinical Prognosis of Patients With Diabetic Kidney Disease

NCT06049550 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT06049550
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06049550 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Influence of the Thickening of Bowman's Capsule on the Clinical Prognosis of Patients With Diabetic Kidney Disease
Lead sponsor
RenJi Hospital
Phase
Observational
Overall status
Unknown status
Start date
October 1, 2023
Completion date
October 31, 2023
Enrollment
250 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic kidney disease, extracellular matrix alteration